Table 1.
Characteristics of 67 patients with COVID-19
| Characteristic | All patients (n = 67) | Common patients (n = 64) | Severe patients (n = 3) |
|---|---|---|---|
| Gender | |||
| Female | 31 (46.3) | 30 (46.9) | 1 (33.3) |
| Male | 36 (53.7) | 34 (50,7) | 2 (66.7) |
| Age (years) | 45.0 ± 15.2 | 44.9 ± 15.5 | 48.3 ± 2.5 |
| 5 ~ 15 | 3 (4.5) | 3 (4.7) | 0 |
| 16 ~ 18 | 1 (1.5) | 1 (1.6) | 0 |
| 19 ~ 45 | 33 (49.3) | 32 (47.8) | 1 (33.3) |
| 46 ~ 65 | 22 (32.8) | 20 (29.9) | 2 (66.7) |
| 65 ~ 72 | 8 (11.9) | 8 (12.5) | 0 |
| Exposure history | |||
| Lived in Wuhan* | 31 (46.3) | 31 (48.4) | 0 |
| Lived in other cities in Hubei province | 3 (4.5) | 2 (3.1) | 1 (33.3) |
| Exposed to patients in Wuhan | 16 (23.9) | 14 (21.9) | 2 (66.7) |
| Exposed to local patients | 15 (22.4) | 15 (23.4) | 0 |
| Exposed to local carriers | 1 (1.5) | 1 (1.6) | 0 |
| No epidemic history | 1 (1.5) | 1 (1.6) | 0 |
| Incubation periods (days)# | 5.3 ± 3.0 (n = 34) | 5.3 ± 3.1 (n = 33) | 3.5 ± 0.7 (n = 1) |
| Period from onset to admission (days) | 3.8 ± 2.3 | 3.8 ± 2.4 | 4.0 ± 1.7 |
| Comorbid illness | |||
| Cardiovascular disease | 1 (1.5) | 1 (1.6) | 0 |
| Digestive system disease | 4 (6.0) | 4 (6.3) | 0 |
| Malignant tumor | 1 (1.5) | 1 (1.6) | 0 |
| Nervous system disease | 0 | 0 | 0 |
| Respiratory system disease | 1 (1.5) | 1 (1.6) | 0 |
| Kidney disease | 0 | 0 | 0 |
| Hypertension | 11 (16.4) | 11 (17.2) | 0 |
| Diabetes | 7 (10.5) | 7 (10.9) | 0 |
| Connective tissue disease* | 1 (1.5) | 0 | 1 (33.3) |
| Smoking | |||
| No smoking history | 62 (92.5) | 59 (92.2) | 3 (100) |
| Previously quit smoking | 2 (3.0) | 2 (3.1) | 0 |
| Current smoker | 3 (4.5) | 3 (4.7) | 0 |
| Alcohol | |||
| No alcohol abuse history | 61 (91.0) | 58 (90.6) | 3 (100) |
| Previously quit drinking | 2 (3.0) | 2 (3.1) | 0 |
| Currently abusing alcohol | 4 (6.0) | 4 (6.2) | 0 |
| Immunosuppressive therapy* | 1 (1.5) | 0 | 1 (33.3) |
| Pregnancy | 1 (1.5) | 1 (1.6) | 0 |
| Symptoms | |||
| Fever | 58 (86.6) | 55 (85.9) | 3 (100) |
| Headache | 2 (3.0) | 2 (3.1) | 0 |
| Dizziness | 3 (4.5) | 3 (4.7) | 0 |
| Muscular soreness | 3 (4.5) | 2 (3.1) | 1 (33.3) |
| Running nose | 3 (4.5) | 3 (4.7) | 0 |
| Sore throat | 8 (11.9) | 8 (12.5) | 0 |
| Cough | 52 (77.6) | 49 (76.6) | 3 (100) |
| Productive cough | 35 (52.2) | 32 (50.0) | 3 (100) |
| Chest distress* | 12 (17.9) | 9 (14.1) | 3 (100) |
| Shortness of breath* | 4 (6.0) | 2 (3.1) | 2 (66.7) |
| Abdominal pain | 2 (3.0) | 2 (3.1) | 0 |
| Diarrhea | 5 (7.4) | 5 (7.8) | 0 |
| Nausea or vomiting | 2 (3.0) | 2 (3.1) | 0 |
| Axillary temperature (°C) | 37.3 ± 0.8 | 37.3 ± 0.8 | 37.5 ± 0.3 |
| Chest CT consistent with pneumonia (n = 65) | |||
| No | 13 (19.4) | 13 (20.3) | 0 |
| Yes | 54 (80.6) | 51 (79.7) | 3 (100) |
| Complications | |||
| Hypoxemia* | 3 (4.5) | 0 | 3 (100) |
Data are expressed as mean ± standard deviation or number (%), where appropriate
Abbreviation: SD standard deviation, CT computerized tomography
#, available for 34 cases, including 31 common cases and three severe cases
* p < 0.05, compared between common and severe cases